EC
CDMO

EntryPoint Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

EntryPoint Capital’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,661
Closed -$219K – 1460
2024
Q2 		$219K Sell
30,661
-3,624
-11% -$27.7K 0.1% 360
2024
Q1 		$230K Sell
34,285
-8,957
-21% -$61.6K 0.21% 74
2023
Q4 		$281K Buy
+43,242
New +$279K 0.27% 31

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.39B AUM 53.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

EntryPoint Capital's CDMO Position: Q3 2024 in Review

EntryPoint Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 30,661 shares — an estimated $219K sold.

EntryPoint Capital first reported a position in CDMO in Q4 2023 and held it in 3 quarters. The position peaked at $281K in Q4 2023. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • EntryPoint Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • EntryPoint Capital sold 30,661 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $219K.
  • EntryPoint Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • EntryPoint Capital's Avid Bioservices, Inc. Common Stock position peaked at $281K in Q4 2023.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.